Ya‐Wen Tsai

738 total citations
62 papers, 341 citations indexed

About

Ya‐Wen Tsai is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Ya‐Wen Tsai has authored 62 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 21 papers in Neurology and 21 papers in Epidemiology. Recurrent topics in Ya‐Wen Tsai's work include COVID-19 Clinical Research Studies (26 papers), Long-Term Effects of COVID-19 (21 papers) and COVID-19 and Mental Health (12 papers). Ya‐Wen Tsai is often cited by papers focused on COVID-19 Clinical Research Studies (26 papers), Long-Term Effects of COVID-19 (21 papers) and COVID-19 and Mental Health (12 papers). Ya‐Wen Tsai collaborates with scholars based in Taiwan, United States and Indonesia. Ya‐Wen Tsai's co-authors include Po‐Yu Huang, Chih‐Cheng Lai, Jheng‐Yan Wu, Min‐Hsiang Chuang, Wan‐Hsuan Hsu, Tinghui Liu, Mei‐Yuan Liu, Yi‐Chen Chen, Po‐Ren Hsueh and Chung‐Han Ho and has published in prestigious journals such as Nature Communications, CHEST Journal and Diabetologia.

In The Last Decade

Ya‐Wen Tsai

53 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ya‐Wen Tsai Taiwan	11	126	122	94	46	44	62	341
Francesco Mariani Italy	10	111 0.9×	136 1.1×	38 0.4×	32 0.7×	43 1.0×	40	286
Alireza Fatemi Iran	10	86 0.7×	70 0.6×	47 0.5×	15 0.3×	40 0.9×	36	294
Dana Maria Albulescu Romania	9	104 0.8×	52 0.4×	27 0.3×	31 0.7×	11 0.3×	34	374
Sneha Sharma India	8	81 0.6×	114 0.9×	47 0.5×	70 1.5×	44 1.0×	20	354
Seyedpouzhia Shojaei Iran	11	45 0.4×	29 0.2×	48 0.5×	21 0.5×	56 1.3×	35	330
Abhigan Babu Shrestha Bangladesh	10	48 0.4×	30 0.2×	78 0.8×	15 0.3×	11 0.3×	72	341
Lucia Diaferio Italy	13	35 0.3×	37 0.3×	34 0.4×	18 0.4×	10 0.2×	19	297
Jihen Jdidi Tunisia	8	79 0.6×	111 0.9×	35 0.4×	15 0.3×	15 0.3×	43	339
Ionela-Larisa Miftode Romania	13	95 0.8×	36 0.3×	104 1.1×	10 0.2×	10 0.2×	41	314
Ayesha Malik Pakistan	10	32 0.3×	32 0.3×	38 0.4×	21 0.5×	10 0.2×	49	305

Countries citing papers authored by Ya‐Wen Tsai

Since Specialization

Citations

This map shows the geographic impact of Ya‐Wen Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya‐Wen Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya‐Wen Tsai more than expected).

Fields of papers citing papers by Ya‐Wen Tsai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya‐Wen Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya‐Wen Tsai. The network helps show where Ya‐Wen Tsai may publish in the future.

Co-authorship network of co-authors of Ya‐Wen Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Ya‐Wen Tsai. A scholar is included among the top collaborators of Ya‐Wen Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya‐Wen Tsai. Ya‐Wen Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsai, Ya‐Wen, et al.. (2026). Tirzepatide versus SGLT2 inhibitors for MASLD: a multi-institutional propensity score-matched cohort study. Hepatology International.

Chen, Chia‐Chen, Wan‐Hsuan Hsu, Ya‐Wen Tsai, et al.. (2025). Clinical Impact of Tirzepatide on Patients With OSA and Obesity. CHEST Journal. 168(3). 785–796. 2 indexed citations

Wu, Jheng‐Yan, Wan‐Hsuan Hsu, Ya‐Wen Tsai, et al.. (2025). A retrospective analysis of combination therapy with GLP-1 receptor agonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in patients with MASLD. Nature Communications. 16(1). 7459–7459. 2 indexed citations

Hsu, Wan‐Hsuan, Ya‐Wen Tsai, Po‐Yu Huang, et al.. (2025). Comparative effectiveness of tirzepatide versus bariatric metabolic surgery in adults with metabolic-associated steatotic liver disease and obesity: a multi-institutional propensity score-matched study. Hepatology International. 19(5). 1087–1097.

Hsu, Chi‐Kuei, et al.. (2024). Disease burden and macrolide resistance of Mycoplasma pneumoniae infection in adults in the Asia-Pacific region. International Journal of Antimicrobial Agents. 64(2). 107205–107205. 9 indexed citations

Hsu, Wan‐Hsuan, et al.. (2024). The preventive effect of inhaled antibiotic against ventilator-associated pneumonia: A systematic review and meta-analysis. International Journal of Antimicrobial Agents. 64(5). 107324–107324. 2 indexed citations

Wang, Jiun‐Ling, Chih‐Cheng Lai, Ya‐Wen Tsai, Wen‐Chien Ko, & Po‐Ren Hsueh. (2024). High ceftazidime-avibactam resistance among carbapenem-resistant Enterobacter species: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014–2021. International Journal of Antimicrobial Agents. 63(4). 107105–107105. 3 indexed citations

Tsai, Ya‐Wen, et al.. (2024). Post-pandemic epidemiological trends of respiratory infectious diseases in Taiwan: A retrospective analysis. Journal of Microbiology Immunology and Infection. 58(2). 233–240. 2 indexed citations

Wang, Jiun‐Ling, et al.. (2024). Global trends in nonsusceptibility rates of Escherichia coli isolates to meropenem and ceftazidime/avibactam: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014–21. International Journal of Antimicrobial Agents. 63(4). 107103–107103. 3 indexed citations

10.

Tsai, Ya‐Wen, Jheng‐Yan Wu, Tinghui Liu, et al.. (2024). Comparative outcomes of SARS-CoV-2 primary and reinfection in older adult patients. Frontiers in Public Health. 12. 1337646–1337646. 1 indexed citations

11.

Wu, Jheng‐Yan, Mei‐Yuan Liu, Min‐Hsiang Chuang, et al.. (2023). Association between nirmatrelvir plus ritonavir and the outcomes of non-hospitalized obese patients with COVID-19. International Journal of Antimicrobial Agents. 62(6). 106984–106984. 9 indexed citations

12.

Chuang, Min‐Hsiang, Jheng‐Yan Wu, Tinghui Liu, et al.. (2023). Efficacy of nirmatrelvir and ritonavir for post‐acute COVID‐19 sequelae beyond 3 months of SARS‐CoV‐2 infection. Journal of Medical Virology. 95(4). e28750–e28750. 22 indexed citations

13.

Huang, Po‐Yu, Jheng‐Yan Wu, Tinghui Liu, et al.. (2023). The clinical efficacy of melatonin in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Medicine. 10. 1171294–1171294. 6 indexed citations

14.

Wu, Jheng‐Yan, Ya‐Wen Tsai, Wan‐Hsuan Hsu, et al.. (2023). Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials. Critical Care. 27(1). 32 indexed citations

15.

Wu, Jheng‐Yan, et al.. (2023). Effect of COVID-19 on the Long-term Cardiovascular Outcomes among Patients with Alcohol Use Disorder: A Retrospective Cohort Study Including 45,842 Patients. Journal of Addiction Medicine. 17(6). e382–e387.

16.

Huang, Po‐Yu, Tinghui Liu, Jheng‐Yan Wu, Ya‐Wen Tsai, & Chih‐Cheng Lai. (2023). Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID‐19: A systematic review and meta‐analysis of randomized control trials. Journal of Medical Virology. 95(3). e28621–e28621. 10 indexed citations

17.

Wu, Jheng‐Yan, Mei‐Yuan Liu, Kuo‐Chuan Hung, et al.. (2023). Clinical efficacy of enteral nutrition feeding modalities in critically ill patients: a systematic review and meta-analysis of randomized controlled trials. European Journal of Clinical Nutrition. 77(11). 1026–1033. 1 indexed citations

18.

Liu, Tinghui, Min‐Hsiang Chuang, Jheng‐Yan Wu, et al.. (2023). Effectiveness of oral antiviral agents on long‐term cardiovascular risk in nonhospitalized patients with COVID‐19: A multicenter matched cohort study. Journal of Medical Virology. 95(8). e28992–e28992. 11 indexed citations

19.

Liu, Tinghui, Jheng‐Yan Wu, Po‐Yu Huang, Ya‐Wen Tsai, & Chih‐Cheng Lai. (2023). The effect of nirmatrelvir‐ritonavir on the long‐term risk of neuropsychiatric sequelae following COVID‐19. Journal of Medical Virology. 95(7). e28951–e28951. 9 indexed citations

20.

Tsai, Ya‐Wen, et al.. (2023). Clinical impacts of the rapid diagnostic method on positive blood cultures. Laboratory Medicine. 55(2). 179–184. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact